529 related articles for article (PubMed ID: 11516721)
1. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
[TBL] [Abstract][Full Text] [Related]
2. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.
Totsuka Y; Hada N; Matsumoto K; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
Carcinogenesis; 1998 Nov; 19(11):1995-2000. PubMed ID: 9855015
[TBL] [Abstract][Full Text] [Related]
3. Mutagens formed from beta-carbolines with aromatic amines.
Totsuka Y; Takamura-Enya T; Nishigaki R; Sugimura T; Wakabayashi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):135-41. PubMed ID: 15036005
[TBL] [Abstract][Full Text] [Related]
4. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
[TBL] [Abstract][Full Text] [Related]
5. Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated products.
Nakano K; Suyama K; Fukazawa H; Uchida M; Wakabayashi K; Shiozawa T; Terao Y
Mutat Res; 2000 Oct; 470(2):141-6. PubMed ID: 11027968
[TBL] [Abstract][Full Text] [Related]
6. Biological significance of aminophenyl-β-carboline derivatives formed from co-mutagenic action of β-carbolines and aniline and o-toluidine and its effect on tumorigenesis in humans: A review.
Totsuka Y; Wakabayashi K
Mutat Res Genet Toxicol Environ Mutagen; 2020; 850-851():503148. PubMed ID: 32247557
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
[TBL] [Abstract][Full Text] [Related]
8. Effect of norharman on the mutagenicity of toluidine metabolites.
Gupta RL; Kaur IP; Gupta AK; Pathak DP; Juneja TR
Toxicol Lett; 1989 Jul; 48(1):75-81. PubMed ID: 2665189
[TBL] [Abstract][Full Text] [Related]
9. Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains.
Oda Y; Totsuka Y; Wakabayashi K; Guengerich FP; Shimada T
Mutagenesis; 2006 Nov; 21(6):411-6. PubMed ID: 17067997
[TBL] [Abstract][Full Text] [Related]
10. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline.
Ohe T; Takata T; Maeda Y; Totsuka Y; Hada N; Matsuoka A; Tanaka N; Wakabayashi K
Mutat Res; 2002 Mar; 515(1-2):181-8. PubMed ID: 11909766
[TBL] [Abstract][Full Text] [Related]
11. Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbolines.
Wakabayashi K; Totsuka Y; Fukutome K; Oguri A; Ushiyama H; Sugimura T
Mutat Res; 1997 May; 376(1-2):253-9. PubMed ID: 9202762
[TBL] [Abstract][Full Text] [Related]
12. Structure of DNA adduct formed with aminophenylnorharman, being responsible for the comutagenic action of norharman with aniline.
Totsuka Y; Takamura-Enya T; Kawahara N; Nishigaki R; Sugimura T; Wakabayashi K
Chem Res Toxicol; 2002 Oct; 15(10):1288-94. PubMed ID: 12387627
[TBL] [Abstract][Full Text] [Related]
13. Identification of new mutagenic heterocyclic amines and quantification of known heterocyclic amines.
Wakabayashi K; Kim IS; Kurosaka R; Yamaizumi Z; Ushiyama H; Takahashi M; Koyota S; Tada A; Nukaya H; Goto S
Princess Takamatsu Symp; 1995; 23():39-49. PubMed ID: 8844794
[TBL] [Abstract][Full Text] [Related]
14. Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline.
Nishigaki R; Totsuka Y; Takamura-Enya T; Sugimura T; Wakabayashi K
Mutat Res; 2004 Aug; 562(1-2):19-25. PubMed ID: 15279827
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of appearance of mutagenicity of N-nitrosodiphenylamine with norharman.
Wakabayashi K; Nagao M; Kawachi T; Sugimura T
IARC Sci Publ; 1982; (41):695-707. PubMed ID: 7141576
[TBL] [Abstract][Full Text] [Related]
16. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
Suzuki J; Kobayashi Y; Monden S; Suzuki S
Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
[TBL] [Abstract][Full Text] [Related]
17. Isolation and chemical--structural identification of a novel aromatic amine mutagen in an ozonized solution of m-phenylenediamine.
Kami H; Watanabe T; Takemura S; Kameda Y; Hirayama T
Chem Res Toxicol; 2000 Mar; 13(3):165-9. PubMed ID: 10725112
[TBL] [Abstract][Full Text] [Related]
18. The effects of S9 mix from rat oesophagus, salivary gland, and liver on the mutagenicity of the rat oesophageal carcinogen N-nitroso-N-methylaniline in the Salmonella typhimurium assay.
Anderson D; Blowers SD; Craddock VM
Mutat Res; 1985; 142(1-2):13-8. PubMed ID: 3883137
[TBL] [Abstract][Full Text] [Related]
19. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse.
Masumura K; Totsuka Y; Wakabayashi K; Nohmi T
Carcinogenesis; 2003 Dec; 24(12):1985-93. PubMed ID: 12970073
[TBL] [Abstract][Full Text] [Related]
20. Isolation and identification of a novel aromatic amine mutagen produced by the Maillard reaction.
Nishigaki R; Watanabe T; Kajimoto T; Tada A; Takamura-Enya T; Enomoto S; Nukaya H; Terao Y; Muroyama A; Ozeki M; Node M; Hasei T; Totsuka Y; Wakabayashi K
Chem Res Toxicol; 2009 Sep; 22(9):1588-93. PubMed ID: 19685856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
